Press Room

2022 CPhI North America

Start
Tuesday, May 17, 2022 - 08:00
End
Thursday, May 19, 2022 - 17:00
Location: Philadelphia, USA
Booth Number: 723
Hovione present at the CPhI NA 2022 in Philadelphia

 

 

We are ready to safely return to CPhI North America in Philadelphia and we look forward to seeing you.

If you would like to connect face-to-face with Hovione’s team at our booth (#723) or if you still prefer to meet us online, always count on our expert’s support. Schedule a meeting with us, our colleagues will be pleased to meet you, both in-person or online.

 

Schedule a meeting button | Hovione
 

 

Hovione offers the best chemistry, particle engineering and drug product capabilities all at the same location. With over 60 years’ experience in process development and manufacturing, we combine our innovative science, the most up-to-date technologies, and multidisciplinary teams to deliver the most impeccable end-to-end solutions, enabling your projects to go to market faster.

 

Find more about CPhI North America

 

Also in the Press Room

See All

The global inhalation contract development and manufacturing organization (CDMO) market is projected to grow from USD 9.13 billion in 2025 to USD 16.68 billion by 2035, reflecting a compound annual growth rate (CAGR) of 5.7% during the forecast period. This growth is driven by the increasing prevalence of respiratory diseases, advancements in inhalation drug delivery technologies, and the rising demand for outsourced manufacturing services in the pharmaceutical industry. The inhalation CDMO market has emerged as a pivotal segment in the pharmaceutical contract development and manufacturing industry. With a rising demand for inhaled therapies for conditions like asthma, COPD, and cystic fibrosis, companies are increasingly outsourcing drug development and production to specialized partners. Inhalation CDMO services cater to both large pharmaceutical corporations and small biotech firms, offering expertise in formulation, device compatibility, regulatory support, and scale-up manufacturing. This market is gaining traction due to the complexity of inhalation drug delivery, which often requires niche technical capabilities and specialized equipment. Outsourcing to an inhalation CDMO allows drug developers to reduce time-to-market while ensuring quality and compliance with global standards. (...) Top Companies Several players dominate the inhalation CDMO market through technological expertise, global reach, and service portfolio diversity: (...) Hovione – Offers particle engineering and inhalation development, with a focus on dry powder inhalers. (...) These companies are continually investing in facilities, talent, and technology to meet evolving customer needs in the inhalation CDMO market.   Read the full article on Pharmiweb.com        

Press Clipping

Inhalation CDMO Market Growth Analysis & Forecast 2025 to 2035

Jun 25, 2025